NCT04569409View on ClinicalTrials.gov

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

December 5, 2024

Study Completion Date

December 5, 2024

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to Diabetic Wagner grade 2 Foot Ulcer

PROCEDURE

Vehicle Sheet

Application of Vehicle sheet to Diabetic Wagner grade 2 Foot Ulcer

Trial Locations (5)

13620

Seoul National University Bundang Hospital, Gyeonggi-do

14647

Bucheon ST. Mary's Hospital, Gyeonggi-do

05505

Asan Medical Center, Seoul

07061

Borame Medical Center, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT04569409 - Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers. | Biotech Hunter | Biotech Hunter